Implantable cardioverter defibrillator treatment : benefits and pitfalls in the currently indicated population Borleffs, C.J.W.

In the current study on the identification of primary prevention ICD patients with ischemic heart disease who do not benefit from ICD treatment, the findings can be summarized as

Methods and results: Ninety-one patients (65±11 years) with previous MI scheduled for ICD implantation underwent cine-MRI to evaluate left ventricular (LV) function and volumes

Univariable analyses demonstrated that ICD indication (secondary vs. primary preven- tion), ischemic cardiomyopathy, early 123-I MIBG SPECT defect score, late 123-I MIBG SPECT

In patients with ischemic heart disease, currently indicated for primary prevention ICD therapy, a baseline spatial QRS-T angle > 100º is associated with a sevenfold risk for the

In this cohort of ICD treated patients with ischemic heart disease and a primary prevention indication for ICD treatment, a post-implant right ventricular stimulation threshold

The main findings of the current study on the incidence, predictors and outcome of inappro- priate shocks can be summarized as follows: (1) the cumulative incidence of inappropriate

The current study aimed to specifically describe the need for CS lead intervention during long-term follow-up and to assess the successfulness of endovascular repositioning. The

Incidence rates for lead failure were found to be higher in the small diameter defibrillation leads with 2.7 (95% CI 1.6-4.4) per 100 lead-years for the Medtronic 7 Fr leads.. Data